196 related articles for article (PubMed ID: 33403221)
1. Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES).
Stredny CM; Case S; Sansevere AJ; Son M; Henderson L; Gorman MP
Child Neurol Open; 2020; 7():2329048X20979253. PubMed ID: 33403221
[TBL] [Abstract][Full Text] [Related]
2. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
3. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
Sheikh Z; Hirsch LJ
Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
[TBL] [Abstract][Full Text] [Related]
4. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
5. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
Hon KL; Leung AKC; Torres AR
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
[TBL] [Abstract][Full Text] [Related]
6. Bridging the Gap: Tailoring an Approach to Treatment in Febrile Infection-Related Epilepsy Syndrome.
Goh Y; Tay SH; Yeo LLL; Rathakrishnan R
Neurology; 2023 Jun; 100(24):1151-1155. PubMed ID: 36797068
[TBL] [Abstract][Full Text] [Related]
7. Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study.
Fox K; Wells ME; Tennison M; Vaughn B
Neurodiagn J; 2017; 57(3):224-233. PubMed ID: 28898171
[TBL] [Abstract][Full Text] [Related]
8. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
[TBL] [Abstract][Full Text] [Related]
9. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman.
Westbrook C; Subramaniam T; Seagren RM; Tarula E; Co D; Furstenberg-Knauff M; Wallace A; Hsu D; Payne E
WMJ; 2019 Oct; 118(3):135-139. PubMed ID: 31682750
[TBL] [Abstract][Full Text] [Related]
10. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal Dexamethasone in Febrile Infection-Related Epilepsy Syndrome: A Case Report.
Mehta NP; Sawdy R; Maloney K; Overlee B; Johnson RK; Howe CL; Farias-Moeller R
Neurol Clin Pract; 2023 Jun; 13(3):e200153. PubMed ID: 37197372
[TBL] [Abstract][Full Text] [Related]
12. Super-refractory status epilepticus in autoimmune encephalitis treated with interleukin-1 receptor antagonist, anakinra.
Choi CH; Ma SH; Ma KK; Leung H; Mok VC
Epileptic Disord; 2021 Jun; 23(3):500-505. PubMed ID: 34057410
[TBL] [Abstract][Full Text] [Related]
13. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
Lai YC; Muscal E; Wells E; Shukla N; Eschbach K; Hyeong Lee K; Kaliakatsos M; Desai N; Wickström R; Viri M; Freri E; Granata T; Nangia S; Dilena R; Brunklaus A; Wainwright MS; Gorman MP; Stredny CM; Asiri A; Hundallah K; Doja A; Payne E; Wirrell E; Koh S; Carpenter JL; Riviello J
Ann Clin Transl Neurol; 2020 Dec; 7(12):2467-2474. PubMed ID: 33506622
[TBL] [Abstract][Full Text] [Related]
14. Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra.
Shrestha A; Wood EL; Berrios-Siervo G; Stredny CM; Boyer K; Vega C; Nangia S; Muscal E; Eschbach K
Front Neurol; 2023; 14():1100551. PubMed ID: 36970506
[TBL] [Abstract][Full Text] [Related]
15. Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - Two different outcomes.
Sa M; Singh R; Pujar S; D'Arco F; Desai N; Eltze C; Hughes E; Al Obaidi M; Eleftheriou D; Tisdall M; Selway R; Cross JH; Kaliakatsos M; Valentin A
Eur J Paediatr Neurol; 2019 Sep; 23(5):749-754. PubMed ID: 31446001
[TBL] [Abstract][Full Text] [Related]
16. Ketogenic Diet as a Treatment for Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome.
Peng P; Peng J; Yin F; Deng X; Chen C; He F; Wang X; Guang S; Mao L
Front Neurol; 2019; 10():423. PubMed ID: 31105638
[No Abstract] [Full Text] [Related]
17. Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation.
Perulli M; Cicala G; Turrini I; Musto E; Quintiliani M; Gambardella ML; Pulitanò SM; Bompard S; Staccioli S; Carmillo L; Di Sante G; Ria F; Veredice C; Contaldo I; Battaglia D
Epilepsy Behav Rep; 2022; 18():100531. PubMed ID: 35356746
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay.
Foiadelli T; Santangelo A; Costagliola G; Costa E; Scacciati M; Riva A; Volpedo G; Smaldone M; Bonuccelli A; Clemente AM; Ferretti A; Savasta S; Striano P; Orsini A
Front Pediatr; 2023; 11():1251914. PubMed ID: 38078329
[TBL] [Abstract][Full Text] [Related]
19. Febrile infection-related epilepsy syndrome treated with anakinra.
Kenney-Jung DL; Vezzani A; Kahoud RJ; LaFrance-Corey RG; Ho ML; Muskardin TW; Wirrell EC; Howe CL; Payne ET
Ann Neurol; 2016 Dec; 80(6):939-945. PubMed ID: 27770579
[TBL] [Abstract][Full Text] [Related]
20. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
Specchio N; Pietrafusa N
Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
